Early detection of respiratory diseases such as asthma, COPD, and lung cancer has significantly benefited patients by enabling timely interventions. Methods like pulmonary function tests, chest X-rays, CT scans, biomarkers, and genetic testing have proven effective. Targeted screening programs have also helped detect these diseases at treatable stages, enhancing survival rates and quality of life.